We and other investigators have recently demonstrated that transcript mutation could be an important factor in the pathophysiology of age-related neurological disorders. The increase in the number of abnormal messenger RNA, with the consequent synthesis of altered proteins, can lead to abnormal metabolic function and cell death. Our recent findings of the presence of multiple aberrant glutamate transporter EAAT2 (excitatory amino acid transporter 2) transcripts, including intron-retention and exon-skipping, in sporadic amyotrophic lateral sclerosis (ALS) as well as in Alzheimer's disease (AD) are good examples. EAAT2 is an astroglial glutamate transporter and is the predominant glutamate transporter. About 60-70 percent of sporadic ALS patients have a 30-95 percent loss of EAAT2 protein in motor cortex and spinal cord. The aberrant EAAT2 transcripts were highly abundant presented in neuropathologically affected areas of ALS patients. The aberrant EAAT2 transcripts, possibly as a consequence of abnormal splicing, can lead to loss of glutamate transporters, with subsequent increase of extracellular glutamate concentration and excitotoxic neurodegeneration. Are there other genes also affected? In this pilot study, we propose to develop a method based on the representational difference analysis (RDA) to identify aberrant transcripts in age-related neurological disorder brains.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Research Grants (R03)
Project #
7R03AG017317-02
Application #
6224286
Study Section
Special Emphasis Panel (ZAG1-BJS-3 (M9))
Project Start
1999-09-30
Project End
2002-08-31
Budget Start
2000-03-01
Budget End
2002-08-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Ohio State University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Chang, Yueming; Kong, Qiongman; Shan, Xiu et al. (2008) Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS One 3:e2849
Kong, Qiongman; Shan, Xiu; Chang, Yueming et al. (2008) RNA oxidation: a contributing factor or an epiphenomenon in the process of neurodegeneration. Free Radic Res 42:773-7
Kong, Qiongman; Stockinger, Michael P; Chang, Yueming et al. (2008) The presence of rRNA sequences in polyadenylated RNA and its potential functions. Biotechnol J 3:1041-6
Chang, Yueming; Stockinger, Michael P; Tashiro, Hirofumi et al. (2008) A novel noncoding RNA rescues mutant SOD1-mediated cell death. FASEB J 22:691-702
Shan, Xiu; Lin, Chien-Liang Glenn (2006) Quantification of oxidized RNAs in Alzheimer's disease. Neurobiol Aging 27:657-62
Shan, Xiu; Tashiro, Hirofumi; Lin, Chien-liang Glenn (2003) The identification and characterization of oxidized RNAs in Alzheimer's disease. J Neurosci 23:4913-21